DK518883A - Fremgangsmaade til fremstilling af 1-oxa-beta-lactam-forbindelser - Google Patents

Fremgangsmaade til fremstilling af 1-oxa-beta-lactam-forbindelser Download PDF

Info

Publication number
DK518883A
DK518883A DK518883A DK518883A DK518883A DK 518883 A DK518883 A DK 518883A DK 518883 A DK518883 A DK 518883A DK 518883 A DK518883 A DK 518883A DK 518883 A DK518883 A DK 518883A
Authority
DK
Denmark
Prior art keywords
oxa
beta
preparing
lactam compounds
lactam
Prior art date
Application number
DK518883A
Other languages
Danish (da)
English (en)
Other versions
DK518883D0 (da
Inventor
David Alfred Hall
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK518883D0 publication Critical patent/DK518883D0/da
Publication of DK518883A publication Critical patent/DK518883A/da

Links

Classifications

    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05BELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
    • H05B3/00Ohmic-resistance heating
    • H05B3/20Heating elements having extended surface area substantially in a two-dimensional plane, e.g. plate-heater
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D505/00Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • DTEXTILES; PAPER
    • D03WEAVING
    • D03DWOVEN FABRICS; METHODS OF WEAVING; LOOMS
    • D03D1/00Woven fabrics designed to make specified articles
    • DTEXTILES; PAPER
    • D03WEAVING
    • D03DWOVEN FABRICS; METHODS OF WEAVING; LOOMS
    • D03D13/00Woven fabrics characterised by the special disposition of the warp or weft threads, e.g. with curved weft threads, with discontinuous warp threads, with diagonal warp or weft
    • DTEXTILES; PAPER
    • D03WEAVING
    • D03DWOVEN FABRICS; METHODS OF WEAVING; LOOMS
    • D03D15/00Woven fabrics characterised by the material, structure or properties of the fibres, filaments, yarns, threads or other warp or weft elements used
    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05BELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
    • H05B3/00Ohmic-resistance heating
    • H05B3/10Heating elements characterised by the composition or nature of the materials or by the arrangement of the conductor
    • H05B3/12Heating elements characterised by the composition or nature of the materials or by the arrangement of the conductor characterised by the composition or nature of the conductive material
    • H05B3/14Heating elements characterised by the composition or nature of the materials or by the arrangement of the conductor characterised by the composition or nature of the conductive material the material being non-metallic
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Textile Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK518883A 1982-11-16 1983-11-14 Fremgangsmaade til fremstilling af 1-oxa-beta-lactam-forbindelser DK518883A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/442,080 US4458071A (en) 1982-11-16 1982-11-16 Process for 1-oxa-β-lactams

Publications (2)

Publication Number Publication Date
DK518883D0 DK518883D0 (da) 1983-11-14
DK518883A true DK518883A (da) 1984-05-17

Family

ID=23755471

Family Applications (1)

Application Number Title Priority Date Filing Date
DK518883A DK518883A (da) 1982-11-16 1983-11-14 Fremgangsmaade til fremstilling af 1-oxa-beta-lactam-forbindelser

Country Status (9)

Country Link
US (1) US4458071A (hu)
EP (1) EP0109302A1 (hu)
JP (1) JPS59104390A (hu)
KR (1) KR840006663A (hu)
DK (1) DK518883A (hu)
GB (1) GB2129803A (hu)
GR (1) GR79030B (hu)
HU (1) HU189774B (hu)
IL (1) IL70220A0 (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4574153A (en) * 1985-03-01 1986-03-04 E. R. Squibb & Sons, Inc. 8-Oxo-2-oxa-1-azabicyclo(4.2.0)octane-3-carboxylic acids
US5239068A (en) * 1987-07-31 1993-08-24 Eli Lilly And Company Bicyclic β-lactam antibiotics
DE3880229T2 (de) * 1987-07-31 1993-08-12 Lilly Co Eli Verfahren zum entschuetzen von 3-aminoazetidinonen.
US4983732A (en) * 1987-07-31 1991-01-08 Eli Lilly And Company Method of deprotection of 3-amino azetidinones
US5142039A (en) * 1987-07-31 1992-08-25 Eli Lilly And Company β-lactam antibiotics

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150156A (en) * 1975-11-21 1979-04-17 Merck & Co., Inc. 7-(Substituted methyl)-3-(substituted thio)-cephalosporins, derivatives and pharmaceutical compositions containing them
AU514377B2 (en) * 1977-02-15 1981-02-05 Shionogi & Co., Ltd. l-OXADETHIACEPHAM COMPOUNDS
US4293493A (en) * 1980-04-07 1981-10-06 Eli Lilly And Company Azetidinone alcohol disulfides and process for cyclization

Also Published As

Publication number Publication date
GB2129803A (en) 1984-05-23
JPS59104390A (ja) 1984-06-16
GB8330282D0 (en) 1983-12-21
DK518883D0 (da) 1983-11-14
GR79030B (hu) 1984-10-02
HU189774B (en) 1986-07-28
EP0109302A1 (en) 1984-05-23
US4458071A (en) 1984-07-03
KR840006663A (ko) 1984-12-01
IL70220A0 (en) 1984-02-29

Similar Documents

Publication Publication Date Title
DK470583D0 (da) Fremgangsmade til fremstilling af 1-phenyl-2-piperidinopropanolderivater
DK350083D0 (da) Fremgangsmade til fremstilling af phenylethanolaminer
DK301986D0 (da) Fremgangsmaade til fremstilling af 1-hydroxyvitamin-d-forbindelser
DK492783D0 (da) Fremgangsmade til fremstilling af 3-aryl-5-pyrazol-derivater
DK95483D0 (da) Fremgangsmade til fremstilling af tetrahydropyranderivater
DK183583D0 (da) Fremgangsmade til fremstilling af benzoazacycloalkyl-spiro-imidazolidiner
DK299483A (da) Fremgangsmaade til fremstilling af n-phosphonomethylglycin
DK211783D0 (da) Fremgangsmade til fremstilling af pyrazolpyridinforbindelser
DK283083D0 (da) Fremgangsmade til fremstilling af n-phosphonomethylglycin
DK159309C (da) Fremgangsmaade til fremstilling af 4-metyl-5-alkylthiometyl-imidazoler
DK40883D0 (da) Fremgangsmade til fremstilling af benzothienylallylaminer
DK369181A (da) Fremgangsmaade til fremstilling af triazolylvinylketonforbindelser
DK518883A (da) Fremgangsmaade til fremstilling af 1-oxa-beta-lactam-forbindelser
DK361983A (da) Fremgangsmaade til fremstilling af meldroejealkaloider
DK394783A (da) Fremgangsmaade til fremstilling af n-phosphonomethylglycin
DK399783A (da) Fremgangsmaade til fremstilling af substituerede 1-pyridyloxy-3-indolylalkylamino-2-propanoler
DK457983D0 (da) Fremgangsmade til fremstilling af beta-lactam
DK299083A (da) Fremgangsmaade til fremstilling af cephalosporinforbindelser
DK385983D0 (da) Fremgangsmade til fremstilling af 1-oxacephamer
DK432683D0 (da) Fremgangsmade til fremstilling af 2-hydroxy-2-phenylethylaminer
DK535083A (da) Fremgangsmaade til fremstilling af cephalosporinforbindelser
DK193983D0 (da) Fremgangsmade til fremstilling af substituerede phenylendiaminer
DK570083D0 (da) Fremgangsmaade til fremstilling af 3-brom-3-methylcepham-forbindelser
DK221383D0 (da) Fremgangsmade til fremstilling af phenylpyridazinforbindelser
DK150615C (da) Fremgangsmaade til fremstilling af substituerede 3-isoxazololer

Legal Events

Date Code Title Description
ATS Application withdrawn